Type II tumours (tumours negative for PD-L1 with low TIL level) were associated with poor disease-free survival in HR−/HER2+ breast cancers, however this was not statistically significant (p = 0.079, Fig. 2). The gene discussed is ERBB2; the disease is breast carcinoma.